PGL 0.00% 44.5¢ prospa group limited.

price target 3.50

  1. 580 Posts.
    I think the potential market for this drug has been greatly overstated. It's a specialty drug, and the market cap has gotten way ahead of itself. Even the best sales projections have a hard time supporting a share price in the $3.20 - $3.60 range. We're going lower.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.